Program / Treatment Design
Kelly Moore, Ph.D. (she/her/hers)
Associate Professor
East Tennessee State University
Johnson City, TN, United States
Arryn Guy, Ph.D. (she/they)
Illinois Institute of Technology
Chicago, IL, United States
Jason Luoma, Ph.D. (he/him/his)
CEO
Portland Psychotherapy Clinic, Research, & Training Center
Portland, OR, United States
Kelly Moore, Ph.D. (she/her/hers)
Associate Professor
East Tennessee State University
Johnson City, TN, United States
Liza Kolbasov, BA
Clinical Psychology PhD Student
Illinois Institute of Technology
Chicago, Illinois, United States
Alicia Lucksted, Ph.D. (she/her/hers)
Associate Professor
Univ of Maryland Baltimore School of Medicine
Baltimore, MD, United States
Trisha Arnold, Ph.D. (she/her/hers)
Postdoctoral Fellow
Brown University
Provience, RI, United States
David Zelaya, Ph.D. (he/him/his)
Assistant Professor
Brown University
Providence, RI, United States
Stigma refers to negative stereotypes, attitudes, feelings, and judgements toward people with certain attributes or histories, leading to status loss and discrimination (Link & Phelan, 2001). Stigma is identified as a primary cause of population health inequity (Hatzenbueler et al., 2013). For example, people with mental illness are often perceived as unpredictable, while people with substance use disorders may be generally viewed as untrustworthy or dangerous. Such negative stereotypes impact how people with these disorders are treated, as well as what resources they have access to within healthcare and other community systems. Self-stigma is a social-cognitive-emotional process in which individuals become aware of and internalize negative stereotypes about a group to which they belong. It is shaped by intersecting systems of oppression, where structural and social forces create cumulative disadvantage (e.g., sexual/gender minority individuals with a substance use disorder navigating both heteronormative stigma and criminalization of substance use). Self-stigma is associated with the “why try” effect, wherein individuals with stigmatized experiences expect others to view them negatively and treat them unfairly, experience hopelessness, and disengage from adaptive behaviors. A robust body of research demonstrates that self-stigma is linked to poorer emotional, social, and behavioral functioning (Van der Kooij et al., 2023; Del Rosal et al., 2021; Earnshaw et al., 2020). In particular, individuals experiencing self-stigma are less likely to seek healthcare, more likely to socially isolate, and are at increased risk for harmful behaviors, leading to serious consequences such as untreated health conditions, overdose, and incarceration. However, self-stigma is modifiable and can be addressed using evidence-based change strategies (Mittal et al., 2012; Yanos et al., 2015; Luoma et al., 2023). This symposium showcases five adaptions of cognitive, behavioral, and motivational interventions to mitigate self-stigma in diverse populations at high risk for adverse health outcomes, including justice-involved individuals, people with serious mental illness, those with substance use disorders, and sexual and gender minorities. These presentations highlight contextual, evidence-based approaches that integrate core therapeutic change principles while addressing intersecting systems of stigma. Presenters will discuss intervention adaptations and share preliminary findings from pilot and larger-scale trials evaluating their effectiveness.
Speaker: Kelly Moore, Ph.D. (she/her/hers) – East Tennessee State University
Speaker: Liza Kolbasov, BA – Illinois Institute of Technology
Co-Author: Arryn Guy, Ph.D. (she/they) – Illinois Institute of Technology
Co-author: Mikey Shock, BA – Illinois Institute of Technology
Co-author: Peyton Erb, BS – Illinois Institute of Technology
Co-author: Kate Linenbach, BS – Illinois Institute of Technology
Co-author: Mayor Manlapid, BA – Brown University
Co-author: Aya Shawari – Illinois Institute of technology
Speaker: Alicia Lucksted, Ph.D. (she/her/hers) – Univ of Maryland Baltimore School of Medicine
Speaker: Trisha Arnold, Ph.D. (she/her/hers) – Brown University
Co-author: Brandon Guadiano, PhD – Brown University
Co-author: Andrew Barnett, PhD – George Washington University School of Medicine and Health Sciences
Co-author: Brooke G. Rogers, M.P.H., Ph.D. – Boston University
Co-author: Sarah Bailey, MS – Rhode Island Hospital
Co-author: Larry Brown, MD – Brown University and Rhode Island Hospital
Speaker: David Zelaya, Ph.D. (he/him/his) – Brown University